Causes of death in HIV patients and the evolution of an AIDS hospice: 1988-2008

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Stewart, Ann ^a,b   Chan Carusone, Soo ^a,c   To, Kent ^d   Schaefer Mcdaniel, Nicole ^a   Halman, Mark ^b,e,f   Grimes, Richard ^g  

^a Casey House Hospice   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Black Creek Community Health Centre   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873863728     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/390406     Document Type: Article

References (20)

1. Rothenberg R., Woelfel M., Stoneburner R., Milberg J., Parker R., Truman B., Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. The New England Journal of Medicine 1987 317 21 1297 1302 2-s2.0-0023616121 (Pubitemid 17153010)
2. Centers for Disease Control and Prevention (CDC), HIV surveillance-United States, 1981-2008. Morbidity and Mortality Weekly Report 2011 60 21 689 693 2-s2.0-79960932930
3. Public Health Agency of Canada, HIV and AIDS in Canada. Surveillance Report to December 2009 2010 Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada. http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/2009/dec/8-eng.php
4. Louie J. K., Hsu L. C., Osmond D. H., Katz M. H., Schwarcz S. K., Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. Journal of Infectious Diseases 2002 186 7 1023 1027 2-s2.0-0036788675 10.1086/343862
5. Antiretroviral Therapy Cohort Collaboration, Causes of death in HIV-1-Infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clinical Infectious Diseases 2010 50 10 1387 1396 2-s2.0-77951819361 10.1086/652283
6. Altice F. L., Kamarulzaman A., Soriano V. V., Schechter M., Friedland G. H., Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet 2010 376 9738 367 387 2-s2.0-77955714260 10.1016/S0140-6736(10)60829-X
7. Walkup J., Blank M. B., Gonzalez J. S., Safren S., Schwartz R., Brown L., Wilson I., Knowlton A., Lombard F., Grossman C., Lyda K., Schumacher J. E., The impact of mental health and substance abuse factors on HIV prevention and treatment. Journal of Acquired Immune Deficiency Syndromes 2008 47 supplement 1 S15 S19 2-s2.0-40049090198 10.1097/QAI.0b013e3181605b26 (Pubitemid 351323596)
8. Hasse B., Ledergerber B., Furrer H., Morbidity and aging in HIV-infected persons: the swiss HIV cohort study. Clinical Infectious Diseases 2011 53 11 1130 1139
9. Guaraldi G., Orlando G., Zona S., Premature age-related comorbidities among HIV-infected persons compared with the general population. Clinical Infectious Diseases 2011 53 11 1120 1126
10. Halman M., Stranks S., Schaefer-McDaniel N., Stewart A., Medical and psychiatric comorbidities: the complexity of care in a sample of patients with late-stage HIV disease. Proceedings of the 18th International AIDS Conference July 2010. Abstract no. CDB0018
11. Centers for Disease Control and Prevention (CDC), Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. Morbidity and Mortality Weekly Report 2008 57 10 1 12 2-s2.0-58149197855
12. Clifford G. M., Polesel J., Rickenbach M., Maso L. D., Keiser O., Kofler A., Rapiti E., Levi F., Jundt G., Fisch T., Bordoni A., De Weck D., Franceschi S., Battegay M., Bernasconi E., Böni J., Bucher H., Bürgisser P., Cattacin S., Cavassini M., Dubs R., Egger M., Elzi L., Erb P., Fantelli K., Fischer M., Flepp M., Fontana A., Francioli P., Furrer H., Gorgievski M., Günthard H., Hirschel B., Kaiser L., Kind C., Klimkait T., Ledergerber B., Lauper U., Opravil M., Paccaud F., Pantaleo G., Perrin L., Piffaretti J. C., Rudin C., Schmid P., Schüpbach J., Speck R., Telenti A., Trkola A., Vernazza P., Weber R., Yerly S., Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute 2005 97 6 425 432 2-s2.0-20144381973 10.1093/jnci/dji072 (Pubitemid 40528605)
13. Shiels M. S., Pfeiffer R. M., Gail M. H., Hall H. I., Li J., Chaturvedi A. K., Bhatia K., Uldrick T. S., Yarchoan R., Goedert J. J., Engels E. A., Cancer burden in the HIV-infected population in the United States. Journal of the National Cancer Institute 2011 103 9 753 762 2-s2.0-79955748687 10.1093/jnci/djr076
14. Simard E. P., Pfeiffer R. M., Engels E. A., Spectrum of cancer risk late after AIDS onset in the United States. Archives of Internal Medicine 2010 170 15 1337 1345 2-s2.0-77955440689 10.1001/archinternmed.2010.253
15. Nguyen M. L., Farrell K. J., Gunthel C. J., Non-AIDS-defining malignancies in patients with HIV in the HAART era. Current Infectious Disease Reports 2010 12 1 46 55 2-s2.0-77249102496 10.1007/s11908-009-0075-6
16. Dauby N., de Wit S., Delforge M., Necsoi V. C., Clumeck N., Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. Journal of the International AIDS Society 2011 14 1, article 16 2-s2.0-79953115053 10.1186/1758-2652-14-16
17. Statistics Canada,. CANSIM, table 105-0501 and Catalogue no. 82-221-X, 2011, http://www40.statcan.gc.ca/l01/cst01/health74b-eng.htm
18. Silverberg M. J., Chao C., Leyden W. A., HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiology, Biomarkers & Prevention 2011 22 12 1 9
19. Hogg R. S., Strathdee S. A., Craib K. J., O'Shaughnessy M. V., Montaner J. S. G., Schechter M. T., Lower socioeconomic status and shorter survival following HIV infection. The Lancet 1994 344 8930 1120 1124 2-s2.0-0028151156 10.1016/S0140-6736(94)90631-9 (Pubitemid 24317632)
20. Alter H., Discovery of non-A, non-B hepatitis and identification of its etiology. American Journal of Medicine 1999 107 6 16S 20S 2-s2.0-0033397954